Literature DB >> 12872442

Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease.

Byung-Soo Kim1, Michael S Goligorsky.   

Abstract

Vascular endothelial growth factor, VEGF, is essential for endothelial cell differentiation (vasculogenesis) and for the sprouting of new capillaries from preexisting vessels (angiogenesis). In addition, there is strong evidence that VEGF is a survival factor allowing the cells to survive and proliferate under conditions of extreme stress. Hypoxia is a key regulator of VEGF gene expression. Besides hypoxia, many cytokines, hormones and growth factors can up-regulate VEGF mRNA expression in various cell types. VEGF is present in the glomerulus of both the fetal and adult kidney. The VEGF produced by glomerular epithelial cell may be responsible for maintenance of the fenestrated phenotype of glomerular epithelial cells, thus facilitating the high rate of glomerular ultrafiltration. But there is little known about the role of VEGF in the tubule. VEGF is thought to be involved in many kinds of kidney diseases. Whereas VEGF has a beneficial role in the pathogenesis in some diseases, it does harmful action in others. Because VEGF is known to be associated with the pathogenesis of some diseases, such as diabetic nephropathy, renal tumor and polycystic kidney disease, the study about the role of VEGF is going to be a target for disease control. On the other hand, an attempt at enhancing the role of VEGF has to be made at diseases like several ARF models and experimental glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872442      PMCID: PMC4531610          DOI: 10.3904/kjim.2003.18.2.65

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  106 in total

1.  Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.

Authors:  R G Tilton; T Kawamura; K C Chang; Y Ido; R J Bjercke; C C Stephan; T A Brock; J R Williamson
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

2.  Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.

Authors:  E O Honkanen; A M Teppo; C Grönhagen-Riska
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

3.  Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia.

Authors:  Antonella N Witmer; Jiapei Dai; Herbert A Weich; Gijs F J M Vrensen; Reinier O Schlingemann
Journal:  J Histochem Cytochem       Date:  2002-06       Impact factor: 2.479

4.  VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells.

Authors:  Jun Chen; Filip Braet; Sergey Brodsky; Talia Weinstein; Victor Romanov; Eisei Noiri; Michael S Goligorsky
Journal:  Am J Physiol Cell Physiol       Date:  2002-05       Impact factor: 4.249

5.  Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells.

Authors:  H Sone; Y Kawakami; Y Okuda; S Kondo; M Hanatani; H Suzuki; K Yamashita
Journal:  Biochem Biophys Res Commun       Date:  1996-04-05       Impact factor: 3.575

6.  VEGF(165) mediates glomerular endothelial repair.

Authors:  T Ostendorf; U Kunter; F Eitner; A Loos; H Regele; D Kerjaschki; D D Henninger; N Janjic; J Floege
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

7.  Vascular permeability factor mRNA and protein expression in human kidney.

Authors:  L F Brown; B Berse; K Tognazzi; E J Manseau; L Van de Water; D R Senger; H F Dvorak; S Rosen
Journal:  Kidney Int       Date:  1992-12       Impact factor: 10.612

8.  Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells.

Authors:  B Williams; A Q Baker; B Gallacher; D Lodwick
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.

Authors:  M Simon; H J Gröne; O Jöhren; J Kullmer; K H Plate; W Risau; E Fuchs
Journal:  Am J Physiol       Date:  1995-02
View more
  4 in total

1.  Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure.

Authors:  Atsuko Y Higashi; Fumiaki Nogaki; Isoroku Kato; Takahiko Ono; Atsushi Fukatsu
Journal:  Clin Exp Nephrol       Date:  2011-10-08       Impact factor: 2.801

2.  Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.

Authors:  Nattawat Klomjit; Xiang-Yang Zhu; Alfonso Eirin; Aditya S Pawar; Sabena M Conley; Amrutesh S Puranik; Christopher M Ferguson; Seo Rin Kim; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2022-09-22       Impact factor: 7.186

3.  Cytoprotective potentialities of carvacrol and its nanoemulsion against cisplatin-induced nephrotoxicity in rats: development of nano-encasulation form.

Authors:  Tamer I M Ragab; Khairy M A Zoheir; Nadia A Mohamed; Abd El-Nasser G El Gendy; Ahmed M Abd-ElGawad; Mohamed F Abdelhameed; Abdel Razik H Farrag; Abdelsamed I Elshamy
Journal:  Heliyon       Date:  2022-03-25

Review 4.  Molecular Mechanisms Involved in Intrarenal Renin-Angiotensin and Alternative Pathways in Diabetic Nephropathy - A Review.

Authors:  Elham Bahreini; Yousef Rezaei-Chianeh; Mohsen Nabi-Afjadi
Journal:  Rev Diabet Stud       Date:  2021-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.